Recomendaçoes para o tratamento da filariose bancroftiana, na infecção e na doença / Recommendations for the treatment of bancroftian filariasis in symptomless and diseased patients
Rev. Soc. Bras. Med. Trop
; Rev. Soc. Bras. Med. Trop;35(1): 43-50, jan.-fev. 2002.
Article
em Pt
| LILACS
| ID: lil-331777
Biblioteca responsável:
BR1.1
RESUMO
The goals of treatment for lymphatic filariasis are to prevent, reverse, or halt progression of disease; and to interrupt transmission of the parasite. Selecting the appropriate therapy for the patient with lymphatic filariasis requires knowledge of the various clinical features of filarial disease and their pathogenesis. In the past, treatment of lymphatic filariasis has focused primarily on antiparasitic chemotherapy; however, for many of the acute and chronic manifestations of lymphatic filariasis, it is now clear that supportive or other forms of clinical care are even more important than antiparasitic medication in order to prevent worsening of the disease. Regardless of the clinical manifestations of filarial disease in a particular patient, the following three components of treatment should, in general, be considered supportive or disease specific clinical care (including hygiene and diet), patient education and counseling and finally, antiparasitic chemotherapy with diethylcarbamazine (DEC) and/or the combination of DEC with ivermectin. The authors also describe the proportional efficacy of diethylcarbamazine and ivermectin, alone or in combination, for use in mass treatment aiming at transmission interruption and the use of hygiene as a public health approach for lymphedema prevention.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Wuchereria bancrofti
/
Filariose Linfática
Tipo de estudo:
Diagnostic_studies
/
Guideline
Limite:
Animals
/
Humans
Idioma:
Pt
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
MEDICINA TROPICAL
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Brasil